Log in
Enquire now
RemeGen

RemeGen

RemeGen is a biopharmaceutical company with operations in China and the United States. The company develops and commercializes biological drugs for autoimmune, oncology, and ophthalmology diseases.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
Company Operating Status
Active
Country
China
China
Crunchbase URL
crunchbase.com/organiz.../remegen
Founded Date
2008
Headquarters
Yantai
Yantai
Industry
Biotechnology
Biotechnology
Biomedical engineering
Biomedical engineering
Drug development
Drug development
Engineering
Engineering
Technology
Technology
Biology
Biology
Investors
Lilly Asia Ventures
Lilly Asia Ventures
Hudson Bay Capital
Hudson Bay Capital
0
OrbiMed
OrbiMed
Vivo Capital
Vivo Capital
Janchor Partners
Janchor Partners
Loyal Valley Capital
Loyal Valley Capital
Lake Bleu Capital
Lake Bleu Capital
Latest Funding Round Date
April 2, 2020
Latest Funding Round Amount (USD)
100,000,000
LinkedIn URL
@company/remegen-biosciences
Location
China
China
Yantai
Yantai
Phone Number
+865353573511
Pitchbook URL
pitchbook.com/profiles...433088-92
Total Funding Amount (USD)
100,000,000
Official Website
remegen.com

Find more companies like RemeGen

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.